Trans-inclusive fertility preservation in the UK: evidence-based clinical guidance, the TransFertility service model and the case for a national pathway
Reproductive BioMedicine Online · 2026
DOI: 10.1016/j.rbmo.2026.105839 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Reproductive BioMedicine Online, 2026. Verfasst von Orestis Tsonis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Fertility Preservation Service, Assisted Conception Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK. Electronic address: Orestis.tsonis@g…. Hauptthemen laut MEDLINE: Fertility Preservation, Transgender Persons. Die Arbeit nennt 83 Literaturangaben.
Abstract (Originalsprache)
Transgender and gender-diverse (TGD) individuals face significant barriers to fertility preservation, yet existing guidance from ESHRE, ASRM, WPATH, and the Endocrine Society remains too general for translation into implementation-ready national pathways. This review synthesizes evidence on the reproductive effects of gender-affirming hormone therapy, clinical outcomes of fertility preservation in TGD populations, the intersection of neurodiversity and gender diversity, and the structural, interpersonal, and intrapersonal barriers to equitable reproductive care-translating this evidence into a trans-inclusive clinical pathway. We present TransFertility, a dysphoria-informed service model developed at Guy's and St Thomas' NHS Foundation Trust, London. Over 39 months, the model achieved a greater than 19-fold increase in referrals, 100% consultation attendance, over 90% treatment initiation, and 96.7% treatment completion, with no serious adverse events. The absence of a UK national pathway for trans-inclusive fertility preservation represents a critical equity gap. We propose that the evidence synthesized here, together with TransFertility's outcomes, provides a robust foundation for national consensus guideline development. This work's principal contribution is demonstrating that dysphoria-informed care can move from theoretical framework to functioning clinical reality: a reproducible, multidisciplinary pathway showing that structural redesign of administrative, clinical, and psychosocial components improves access, engagement, and treatment completion for TGD individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fertility Preservation Service, Assisted Conception Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK. Electronic address: Orestis.tsonis@gmail.com.
- Fertility Preservation Service, Assisted Conception Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK.
- Assisted Conception Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Zitieren
APA
Tsonis, O., Shanbhag, N., Grace, J., El-Toukhy, T., Khalaf, Y., & Kopeika, J. (2026). Trans-inclusive fertility preservation in the UK: evidence-based clinical guidance, the TransFertility service model and the case for a national pathway. Reproductive BioMedicine Online. https://doi.org/10.1016/j.rbmo.2026.105839
Vancouver
Tsonis O, Shanbhag N, Grace J, El-Toukhy T, Khalaf Y, Kopeika J. Trans-inclusive fertility preservation in the UK: evidence-based clinical guidance, the TransFertility service model and the case for a national pathway. Reproductive BioMedicine Online. 2026. doi:10.1016/j.rbmo.2026.105839
BibTeX
@article{Tsonis2026,
author = {Tsonis, Orestis and Shanbhag, Neha and Grace, Jan and El-Toukhy, Tarek and Khalaf, Yacoub and Kopeika, Julia},
title = {Trans-inclusive fertility preservation in the UK: evidence-based clinical guidance, the TransFertility service model and the case for a national pathway},
journal = {Reproductive BioMedicine Online},
year = {2026},
doi = {10.1016/j.rbmo.2026.105839}
}
EUVIMED